Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CBO scores contact lens proposal

This article was originally published in The Gray Sheet

Executive Summary

Despite the imposition of more stringent federal requirements, neither sellers, prescribers nor manufacturers of decorative, non-corrective lenses would be saddled with "significant" additional expenses following implementation of legislation (S 172) to regulate all contact lenses as devices, according to a Congressional Budget Office cost estimate released April 15. CBO estimates that the direct costs of the mandates in the bill would not exceed $123 mil. in 2005, with FDA incurring additional expenses of less than $500,000 annually. Sponsored by Sens. Mike DeWine (R-Ohio) and Edward Kennedy (D-Mass.) and marked up unanimously March 9 by the Senate Health Committee, S 172 emerged following reports of teenagers who developed serious eye problems after using nonprescription cosmetic lenses purchased from unauthorized vendors (1"The Gray Sheet" March 14, 2005, p. 16)...

You may also be interested in...

FDA to oversee cosmetic lenses

The Senate unanimously approves legislation (S 172) July 29 to have non-corrected lenses regulated as medical devices. The bill addresses concerns about the availability of decorative and other non-corrective lenses to minors without a prescription or proper fitting from a licensed professional. The legislation is not anticipated to impose significant additional expenses on sellers, prescribers or manufacturers of the products (1"The Gray Sheet" April 25, 2005, In Brief)...

FDA Regulation Of Non-Corrective Contact Lenses Required By Senate Bill

A bill that would regulate all contact lenses as medical devices will be brought to the Senate floor later this year after being marked up unanimously March 9 by the Health Committee

Big Pharma BD Execs Tell Start-Ups: Don’t Be Afraid To Ask Us For Help

Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts